Different Disease-modifying Treatments do not Affect Quality of Life of Multiple Sclerosis Patients
نویسندگان
چکیده
منابع مشابه
Non-adherence to Disease-Modifying Treatments in Patients with Multiple Sclerosis
Background: Multiple Sclerosis (MS) is a debilitating disease of the central nervous system. Usually, long-term MS medications are injected intramuscularly or subcutaneously, making them intolerable for many MS patients. Objectives: In the present study, the rate and the causes of non-adherence to MS disease-modifying drugs (DMDs) were assessed in patients with MS. Materials and Methods: Two ...
متن کاملGroup Quality of Life Therapy in Patients with Multiple Sclerosis
Objective: Multiple sclerosis (MS) has several physical, psychological, and psychiatric symptoms. Regarding the psychological impact of MS on aspects of life, this study sought to examine the effect of group quality of life therapy on depression and anxiety in these patients. Methods: Two groups of 15 matched patients with MS were randomly assigned to experimental and control groups after co...
متن کاملHealth-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs
Multiple sclerosis (MS) has a profound impact on health-related quality of life (HRQoL), a comprehensive subjective measure of the patient's health status. Assessment of HRQoL informs on the potential advantages and disadvantages of disease-modifying drugs (DMDs) beyond their effects on observer-based disability and magnetic resonance imaging abnormalities. This article reviews published data f...
متن کاملDiagnosis and disease modifying treatments in multiple sclerosis.
Multiple sclerosis (MS) refers to scattered areas of hardening found on sectioning central nervous system tissue of affected people, usually after many years of illness. It rarely causes early death but is the commonest cause of neurological disability among young people. Overall results from controlled trials over the past 50 years have been rather disappointing but the comparatively recent li...
متن کاملDisease modifying treatments and symptomatic drugs for cognitive impairment in multiple sclerosis: where do we stand?
Cognitive dysfunction is frequent in multiple sclerosis patients and has important and negative consequences for daily activities and quality of life of subjects. Disease modifying treatments for multiple sclerosis reduce the incidence of relapses and may prevent disease progression, but the influence on cognitive impairment is unclear, due to several limitations of the available studies. Moreo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Scientific Neurology
سال: 2021
ISSN: 2582-1121
DOI: 10.31080/asne.2021.04.0318